Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1300 CAD | 0.00% |
|
-7.14% | - |
| Market Cap | 49.09M 34.53M 30.23M 27.78M 25.89M 3.29B 49.83M 333M 129M 1.62B 130M 127M 5.58B | P/E 2026 * |
-4.33x | P/E 2027 * | -3.25x |
|---|---|---|---|---|---|
| Enterprise Value | 49.09M 34.53M 30.23M 27.78M 25.89M 3.29B 49.83M 333M 129M 1.62B 130M 127M 5.58B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.82x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -7.14% | ||
| Current month | -3.70% | ||
| 1 month | -16.13% | ||
| 3 months | -13.33% | ||
| 6 months | +4.00% |
| 1 week | 0.13 |  | 0.14 |
| 1 month | 0.12 | | 0.17 |
| Current year | 0.12 | | 0.2 |
| 1 year | 0.12 | | 0.21 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 2024-08-11 |
James Parsons
DFI | Director of Finance/CFO | 60 | 2024-10-10 |
David Burke
IRC | Investor Relations Contact | - | 2024-10-10 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 2012-04-18 |
Steven Sangha
BRD | Director/Board Member | - | 2023-04-23 |
David Paterson
BRD | Director/Board Member | - | 2024-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-21 | Option | Chairman | 228,912 | 0.0658% | ||
| 05-21 | Option | Director | 166,482 | 0.0479% | ||
| 05-21 | Option | Director | 260,000 | 0.0748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -7.14% | -16.13% | -86.87% | 34.56M | |
| +4.20% | -1.85% | -17.39% | +9.58% | 125B | |
| +0.04% | -1.01% | +1.39% | -6.08% | 12.77B | |
| +7.83% | +2.71% | +43.32% | +112.86% | 8.71B | |
| +2.29% | +7.17% | -46.92% | -72.29% | 4.07B | |
| +4.16% | +8.39% | +25.37% | +43.89% | 2.73B | |
| +2.53% | +23.07% | -7.66% | -13.04% | 1.89B | |
| +3.55% | +8.85% | -0.99% | -23.29% | 1.67B | |
| -5.25% | -5.89% | +179.33% | +133.76% | 1.46B | |
| Average | +2.15% | +0.30% | +17.81% | +10.95% | 17.61B | |
| Weighted average by Cap. | +3.90% | +2.89% | -10.46% | +12.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.52M 3.08M 2.83M 2.64M 335M 5.07M 33.91M 13.18M 165M 13.21M 12.93M 568M |
| Net income | -12.83M -9.02M -7.9M -7.26M -6.77M -860M -13.02M -86.99M -33.82M -423M -33.89M -33.16M -1.46B | -19.77M -13.91M -12.17M -11.19M -10.43M -1.33B -20.07M -134M -52.14M -652M -52.25M -51.12M -2.25B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | $0.1300 | 0.00% | 95,000 |
| 26-07-02 | $0.1300 | -3.70% | 60,513 |
| 26-06-30 | $0.1350 | 0.00% | 161,770 |
| 26-06-29 | $0.1350 | -3.57% | 22,016 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1300CAD
Average target price
0.4500CAD
Spread / Average Target
+246.15%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
